Nanospectra
  • COMPANY
  • TECHNOLOGY
  • MEDIA
  • CONTACT
  • PATIENTS
  • CLINICIANS
Select Page

PRESS RELEASES 

  • Nanospectra Biosciences Announces Enrollment Completion of Pivotal Study of AuroLase Therapy for Ablation of Prostate Tissue
    November 2, 2021
  • Nanospectra Biosciences Raises First Tranche of Series B-1 Funding Led by Sirtex Medical
    September 8, 2020
  • Nanospectra Biosciences Announces Four Additional Prestigious Trial Sites for Pivotal AuroLase Study
    August 4, 2020
  • 1
  • 2
  • 3
  • 4
MEDIA

NEWS

  • September 30, 2019
     ProstateCancerNewsToday.com
    Focal Therapy, AuroLase, Shows Good Safety and Potential Effectiveness in Pilot Clinical Trial         Learn more
  • September 3, 2019
     MedicalDeviceDaily.com
    Nanospectra Biosciences sees publication of positive results with Aurolase therapy         Learn more
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
arrow-left arrow-right

BLOG HEADLINE 

No items found

Company

  • Management
  • Advisors
  • Partners
  • Board
  • Investors

Technology

  • Overview
  • Scientific Publications
  • Animation

Media

  • News
  • Press Releases
  • Patients
  • Clinicians
    • Facebook
    • Twitter